Article Versions Notes

Calvo A, Alonso S, Prieto E, Ascaso-del-Rio A, Ortuño J, Fernandez N, Portolés A. Single and Multiple Dose PK–PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers. Journal of Clinical Medicine. 2022; 11(3):858. https://doi.org/10.3390/jcm11030858

Calvo, Aitana, Saioa Alonso, Esther Prieto, Ana Ascaso-del-Rio, Jordi Ortuño, Nieves Fernandez, and Antonio Portolés. 2022. "Single and Multiple Dose PK–PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers" Journal of Clinical Medicine 11, no. 3: 858. https://doi.org/10.3390/jcm11030858

Calvo, A., Alonso, S., Prieto, E., Ascaso-del-Rio, A., Ortuño, J., Fernandez, N., & Portolés, A. (2022). Single and Multiple Dose PK–PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers. Journal of Clinical Medicine, 11(3), 858. https://doi.org/10.3390/jcm11030858